Research ArticleOriginal Research

Impact of an Electronic Health Record (EHR) Reminder on Human Papillomavirus (HPV) Vaccine Initiation and Timely Completion

Mack T. Ruffin, Melissa A. Plegue, Pamela G. Rockwell, Alisa P. Young, Divya A. Patel and Mark W. Yeazel
The Journal of the American Board of Family Medicine May 2015, 28 (3) 324-333; DOI: https://doi.org/10.3122/jabfm.2015.03.140082

References

  1. 1.↵
    1. Markowitz LE,
    2. Dunne EF,
    3. Saraiya M,
    4. et al
    . Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007;56:1–24.
    OpenUrlPubMed
  2. 2.↵
    Centers for Disease Control and Prevention. Media advisory: ACIP recommends all 11–12 year-old males get vaccinated against HPV. October 25, 2011. Available from: http://www.cdc.gov/media/releases/2011/a1025_ACIP_hpv_Vote.html. Accessed June 10, 2014.
  3. 3.↵
    Centers for Disease Control and Prevention. Human papillomavirus vaccination coverage among adolescent girls, 2007–2012, and postlicensure vaccine safety monitoring, 2006–2013–United States. MMWR Morb Mortal Wkly Rep 2013;62:591–5.
    OpenUrlPubMed
  4. 4.↵
    1. Jain N,
    2. Euler GL,
    3. Shefer A,
    4. Lu P,
    5. Yankey D,
    6. Markowitz L
    . Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States. National Immunization Survey-Adult 2007. Prev Med 2009;48:426–31.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Dempsey A,
    2. Cohn L,
    3. Dalton V,
    4. Ruffin M
    . Worsening disparities in HPV vaccine utilization among 19–26 year old women. Vaccine 2011;29:528–34.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Reiter PL,
    2. Cates JR,
    3. McRee AL,
    4. et al
    . Statewide HPV vaccine initiation among adolescent females in North Carolina. Sex Transm Dis 2010;37:549–56.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Tan W,
    2. Viera AJ,
    3. Rowe-West B,
    4. Grimshaw A,
    5. Quinn B,
    6. Walter EB
    . The HPV vaccine: are dosing recommendations being followed? Vaccine 2011;29:2548–54.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Widdice LE,
    2. Bernstein DI,
    3. Leonard AC,
    4. Marsolo KA,
    5. Kahn JA
    . Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics 2011;127:77–84.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Chao C,
    2. Velicer C,
    3. Slezak JM,
    4. Jacobsen SJ
    . Correlates for completion of 3-dose regimen of HPV vaccine in female members of a managed care organization. Mayo Clin Proc 2009;84:864–70.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Cook RL,
    2. Zhang J,
    3. Mullins J,
    4. et al
    . Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in Medicaid. J Adolesc Health 2010;47:596–9.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Rosenthal SL,
    2. Weiss TW,
    3. Zimet GD,
    4. Ma L,
    5. Good MB,
    6. Vichnin MD
    . Predictors of HPV vaccine uptake among women aged 19–26: importance of a physician's recommendation. Vaccine 2011;29:890–5.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Dempsey AF,
    2. Patel DA
    . HPV vaccine acceptance, utilization and expected impacts in the U.S.: where are we now? Hum Vaccin 2010;6.
  13. 13.↵
    1. Holman DM,
    2. Benard V,
    3. Roland KB,
    4. Watson M,
    5. Liddon N,
    6. Stokley S
    . Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr 2014;168:76–82.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Szilagyi PG,
    2. Bordley C,
    3. Vann JC,
    4. et al
    . Effect of patient reminder/recall interventions on immunization rates: a review. JAMA 2000;284:1820–7.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Fiks AG,
    2. Grundmeier RW,
    3. Mayne S,
    4. et al
    . Effectiveness of decision support for families, clinicians, or both on HPV vaccine receipt. Pediatrics 2013;131:1114–24.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Suh CA,
    2. Saville A,
    3. Daley MF,
    4. et al
    . Effectiveness and net cost of reminder/recall for adolescent immunizations. Pediatrics 2012;129:e1437–45.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Szilagyi PG,
    2. Schaffer S,
    3. Barth R,
    4. et al
    . Effect of telephone reminder/recall on adolescent immunization and preventive visits: results from a randomized clinical trial. Arch Pediatr Adolesc Med 2006;160:157–63.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Nease DE Jr.,
    2. Green LA
    . ClinfoTracker: a generalizable prompting tool for primary care. J Am Board Fam Pract 2003;16:115–23.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Little R,
    2. Rubin D
    . Statistical analysis with missing data. New York: J Wiley & Sons; 1987.
  20. 20.↵
    1. van Ryn M,
    2. Fu SS
    . Paved with good intentions: do public health and human service providers contribute to racial/ethnic disparities in health? Am J Public Health 2003;93:248–55.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Chao C,
    2. Velicer C,
    3. Slezak JM,
    4. Jacobsen SJ
    . Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol 2010;171:357–67.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Major B,
    2. Mendes WB,
    3. Dovidio JF
    . Intergroup relations and health disparities: a social psychological perspective. Health Psychol 2013;32:514–24.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Dovidio JF,
    2. Penner LA,
    3. Albrecht TL,
    4. Norton WE,
    5. Gaertner SL,
    6. Shelton JN
    . Disparities and distrust: the implications of psychological processes for understanding racial disparities in health and health care. Soc Sci Med 2008;67:478–86.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Burgess DJ,
    2. van Ryn M,
    3. Grill J,
    4. et al
    . Presence and correlates of racial disparities in adherence to colorectal cancer screening guidelines. J Gen Intern Med 2011;26:251–8.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Herweijer E,
    2. Leval A,
    3. Ploner A,
    4. et al
    . Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma. JAMA 2014;311:597–603.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    1. Safaeian M,
    2. Porras C,
    3. Pan Y,
    4. et al
    ; CVT Group. Durable antibody responses following one dose of the bivalent human papillomavirus l1 virus-like particle vaccine in the Costa Rica Vaccine Trial. Cancer Prev Res (Phila) 2013;6:1242–50.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Zimmerman RK,
    2. Nowalk MP,
    3. Lin CJ,
    4. et al
    . Randomized trial of an alternate human papillomavirus vaccine administration schedule in college-aged women. J Womens Health (Larchmt) 2010;19:1441–7.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords